HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,285,563 | +5.2% | 14,351 | 0.0% | 0.00% | +50.0% |
Q2 2023 | $1,221,844 | +2.9% | 14,351 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $1,187,545 | +6.7% | 14,351 | +1.4% | 0.00% | 0.0% |
Q4 2022 | $1,112,976 | -9.7% | 14,151 | -15.0% | 0.00% | 0.0% |
Q3 2022 | $1,233,000 | +12.3% | 16,651 | -1.1% | 0.00% | 0.0% |
Q2 2022 | $1,098,000 | +3.1% | 16,841 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $1,065,000 | +19.3% | 16,841 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $893,000 | -69.4% | 16,841 | -59.3% | 0.00% | -66.7% |
Q3 2021 | $2,920,000 | +5.9% | 41,371 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $2,757,000 | -40.0% | 41,371 | 0.0% | 0.01% | -40.0% |
Q1 2021 | $4,593,000 | -24.7% | 41,371 | -19.5% | 0.01% | -28.6% |
Q4 2020 | $6,100,000 | +32.8% | 51,364 | -2.5% | 0.01% | +16.7% |
Q3 2020 | $4,594,000 | -2.6% | 52,664 | 0.0% | 0.01% | -7.7% |
Q2 2020 | $4,716,000 | -10.1% | 52,664 | 0.0% | 0.01% | -27.8% |
Q1 2020 | $5,248,000 | +3.6% | 52,664 | +19.5% | 0.02% | +38.5% |
Q4 2019 | $5,064,000 | – | 44,071 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |